Related Experiment Video
Updated: May 11, 2026
06:55
A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus)
Published on: February 27, 2018
Intratympanic dexamethasone injection for refractory tinnitus: prospective placebo-controlled study
Seong Jun Choi1, Jong Bin Lee, Hye Jin Lim
1Department of Otorhinolaryngology, College of Medicine, Konyang University, Daejon.
The Laryngoscope
|April 27, 2013
Summary
Intratympanic dexamethasone injections (ITDI) showed no significant effectiveness for refractory tinnitus in a randomized controlled trial. Further research is needed to identify specific cases where ITDI might be beneficial.
Area of Science:
- Otolaryngology
- Neurology
- Pharmacology
Background:
- Refractory tinnitus significantly impacts quality of life.
- Limited effective treatment options exist for persistent tinnitus.
Purpose of the Study:
- To evaluate the efficacy of intratympanic dexamethasone injections (ITDI) for treating refractory tinnitus.
Main Methods:
- A prospective, randomized, double-blind, placebo-controlled study.
- Thirty patients with refractory tinnitus received either ITDI or saline injections.
- Outcomes were assessed using questionnaires, Tinnitus Handicap Index (THI), and loudness matching tests after 4 weeks.
Main Results:
- No statistically significant differences in tinnitus improvement were observed between the ITDI and saline groups.
- Effectiveness rates for ITDI were 33.3% across assessed parameters, compared to 26.7%-40.0% for saline.
- Subgroup analysis for tinnitus under 6 months also showed no significant difference.
Conclusions:
- Intratympanic dexamethasone injections may not be an effective treatment for refractory tinnitus.
- The use of ITDI for tinnitus should be reserved for specific, carefully selected cases.
